Consequences of intra-articular bleeding in haemophilia: Science to clinical practice and beyond

Haemophilia

Volumn 18, Issue SUPPL.4, 2012, Pages 112-119

  Forsyth, A L ^a   Rivard, G E ^b   Valentino, L A ^c   Zourikian, N ^b   Hoffman, M ^d   Monahan, P E ^e   Van Meegeren, M E R ^f   Forriol, F ^g  

^a CHRISTIANA CARE HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MONTREAL   (Canada)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^g UNIVERSIDAD SAN PABLO CEU   (Spain)

Author keywords

Angiogenesis; Cartilage; Haemophilia; Hemarthropathy; Hemarthrosis; Inflammation; Synovitis

Indexed keywords

BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; CELECOXIB; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DEXAMETHASONE; ETANERCEPT; ICE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; MR 16 1; OSTEOGENIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR; PREDNISOLONE; RECOMBINANT OSTEOGENIC PROTEIN 1; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BIOMECHANICS; BLOOD CLOTTING; BONE GRAFT; BONE INJURY; BONE MATRIX; CARTILAGE; CARTILAGE MATRIX; CLINICAL PRACTICE; DISEASE MODEL; DRUG MECHANISM; HEMARTHROSIS; HEMOPHILIA A; HEMOPHILIA B; HEMOPHILIC ARTHROPATHY; HEMOSTASIS; HUMAN; INFLAMMATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSEUDARTHROSIS; SCIENCE; SYNOVITIS; THROMBOCYTE FUNCTION; TISSUE ENGINEERING; TREATMENT CONTRAINDICATION; TREATMENT DURATION; TURNOVER TIME; WOUND HEALING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CRYOTHERAPY; CYCLOOXYGENASE INHIBITORS; CYTOKINES; DISEASE MODELS, ANIMAL; HEMARTHROSIS; HEMOPHILIA A; HEMOPHILIA B; HUMANS; MICE; TUMOR NECROSIS FACTOR-ALPHA; WOUND HEALING;

EID: 84862840738     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2012.02835.x     Document Type: Article

References (86)

1. Jansen NW, Roosendaal G, Wenting MJ et al. Very rapid clearance after a joint bleed in the canine knee cannot prevent adverse effects on cartilage and synovial tissue. Osteoarthritis Cartilage 2009; 17: 433-40.
2. Ovlisen K, Kristensen AT, Jensen AL, Tranholm M. IL-1 beta, IL-6, KC and MCP-1 are elevated in synovial fluid from haemophilic mice with experimentally induced haemarthrosis. Haemophilia 2009; 15: 802-10.
3. Sun J, Hu G, Monahan PE. TNF-alpha antagonists augment factor replacement to prevent arthropathy in hemophilic mice. J Thromb Haemost 2009; 7: 225.
4. Hoffman M, Pradhan S, Monroe DM. Celecoxib does not delay cutaneous wound healing in haemophilia B mice. Haemophilia 2009; 15: 615-6.
5. Stockwell RA. The interrelationship of cell density and cartilage thickness in mammalian articular cartilage. J Anat 1971; 109: 411-21.
6. Pergantou H et al. Comparative study of validity of clinical, X-ray and magnetic resonance imaging scores in evaluation and management of haemophilic arthropathy in children. Haemophilia 2006; 12: 241-7.
7. Johnson EE, Urist MR. Human bone morphogenetic protein allografting for reconstruction of femoral nonunion. Clin Orthop 2000; 371: 61-74.
8. Wolberg AS, Meng ZH, Monroe DM 3rd, Hoffman M. A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet function. J Trauma 2004; 56: 1221-8.
9. Gilbert MS. In: Schulman S. ed. Musculoskeletal Complications of Hemophilia: The Joint. Montreal: World Federation of Hemophilia, 1997: 2.
10. Swanton MC. Hemophilic arthropathy in dogs. Lab Invest 1959; 8: 1269-77.
11. Pollmann H et al. When are children diagnosed as having severe haemophilia and when do they start to bleed? A 10-year single-centre PUP study. Eur J Pediatr 1999. 158: S166-70.
12. Aronstam A, Rainsford SG, Painter MJ. Patterns of bleeding in adolescents with severe haemophilia A. Br Med J 1979; 1: 469-70.
13. Hoots WK. Pathogenesis of hemophilic arthropathy. Semin Hematol 2006; 43: S18-22.
14. Hoffman M, Monroe DM. Wound healing in haemophilia - breaking the vicious cycle. Haemophilia 2010; 16: 13-8.
15. Kirsner RS, Eaglstein WH. The wound healing process. Dermatol Clin 1993; 11: 629-40.
16. Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nuseir N. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 1987; 329: 630-2.
17. Hubner G, Brauchle M, Smola H, Madlener M, Fassler R, Werner S. Differential regulation of pro-inflammatory cytokines during wound healing in normal and glucocorticoid-treated mice. Cytokine 1996; 8: 548-56.
18. Roosendaal G, Mauser-Bunschoten EP, De Kleijn P et al. Synovium in haemophilic arthropathy. Haemophilia 1998; 4: 502-5.
19. Acharya SS, Kaplan RN, Macdonald D, Fabiyi OT, DiMichele D, Lyden D. Neoangiogenesis contributes to the development of hemophilic synovitis. Blood 2011; 117: 2484-93.
20. Acharya SS. Exploration of the pathogenesis of haemophilic joint arthropathy: understanding implications for optimal clinical management. Br J Haematol 2012; 156: 13-23.
21. Hooiveld MJ, Roosendaal G, van den Berg HM, Bijlsma JW, Lafeber FP. Haemoglobin-derived iron-dependent hydroxyl radical formation in blood-induced joint damage: an in vitro study. Rheumatology (Oxford) 2003; 42: 784-90.
22. Hoffman M, Harger A, Lenkowski A, Hedner U, Roberts HR, Monroe DM. Cutaneous wound healing is impaired in hemophilia B. Blood 2006; 108: 3053-60.
23. McDonald A, Hoffman M, Hedner U, Roberts HR, Monroe DM. Restoring hemostatic thrombin generation at the time of cutaneous wounding does not normalize healing in hemophilia B. J Thromb Haemost 2007; 5: 1577-83.
24. Kisker CT, Burke C. Double-blind studies on the use of steroids in the treatment of acute hemarthrosis in patients with hemophilia. N Engl J Med 1970; 282: 639-42.
25. Medeiros D, Laufenberg JA, Miller KL, Buchanan GR. Short-term oral corticosteroid therapy for acute haemarthrosis in haemophilia patients with high-titre inhibitors. Haemophilia 2007; 13: 85-9.
26. Rodriguez-Merchan EC, Villar A, Orbe A, Magallon M. Intra-articular methylprednisolone therapy in chronic hemophilic synovitis of the knee. Rev Clin Esp 1994; 194: 480-2.
27. Shupak R, Teitel J, Garvey MB, Freedman J. Intraarticular methylprednisolone therapy in hemophilic arthropathy. Am J Hematol 1988; 27: 26-9.
28. Fernandez-Palazzi F, Caviglia HA, Salazar JR, Lopez J, Aoun R. Intraarticular dexamethasone in advanced chronic synovitis in hemophilia. Clin Orthop Relat Res 1997; 343: 25-9.
29. Rattray B, Nugent DJ, Young G. Celecoxib in the treatment of haemophilic synovitis, target joints, and pain in adults and children with haemophilia. Haemophilia 2006; 12: 514-7.
30. Rattray B, Nugent DJ, Young G. Rofecoxib as adjunctive therapy for haemophilic arthropathy. Haemophilia 2005; 11: 240-4.
31. Valentino LA, Hakobyan N. Histological changes in murine haemophilic synovitis: a quantitative grading system to assess blood-induced synovitis. Haemophilia 2006; 12: 654-62.
32. van der Sluijs JA, Geesink RG, van der Linden AJ, Bulstra SK, Kuyer R, Drukker J. The reliability of the Mankin score for osteoarthritis. J Orthop Res 1992; 10: 58-61.
33. Jansen NW, Roosendaal G, Hooiveld MJ et al. Interleukin-10 protects against blood-induced joint damage. Br J Haematol 2008; 142: 953-61.
34. Vinckier F, Vermylen J. Wound healing following dental extractions in rabbits: effects of tranexamic acid, warfarin anti-coagulation, and socket packing. J Dent Res 1984; 63: 646-9.
35. Drew AF, Liu H, Davidson JM, Daugherty CC, Degen JL. Wound-healing defects in mice lacking fibrinogen. Blood 2001; 97: 3691-8.
36. te Velde EA, Wagenaar GT, Reijerkerk A et al. Impaired healing of cutaneous wounds and colonic anastomoses in mice lacking thrombin-activatable fibrinolysis inhibitor. J Thromb Haemost 2003; 1: 2087-96.
37. Sindrilaru A, Peters T, Wieschalka S et al. An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J Clin Invest 2011; 121: 985-97.
38. Hoffman M, Monroe DM. Inflammation does not predispose to bleeding in hemophilia. J Thromb Haemost 2010; 8: 2583-5.
39. Roosendaal G, Vianen ME, van den Berg HM, Lafeber FP, Bijlsma JW. Cartilage damage as a result of hemarthrosis in a human in vitro model. J Rheumatol 1997; 24: 1350-4.
40. Roosendaal G, Vianen ME, Marx JJ, van den Berg HM, Lafeber FP, Bijlsma JW. Blood-induced joint damage: a human in vitro study. Arthritis Rheum 1999; 42: 1025-32.
41. Hooiveld M, Roosendaal G, Wenting M, van den Berg M, Bijlsma J, Lafeber F. Short-term exposure of cartilage to blood results in chondrocyte apoptosis. Am J Pathol 2003; 162: 943-51.
42. Mastbergen SC, Lafeber FP. Animal models of osteoarthritis - why choose a larger model? US Musculoskeletal Review 2009; 4: 11-4.
43. Rodriguez NI, Hoots WK. Advances in hemophilia: experimental aspects and therapy. Pediatr Clin North Am 2008; 55: 357-76, viii.
44. Roosendaal G et al. Blood-induced joint damage: a canine in vivo study. Arthritis Rheum 1999; 42: 1033-9.
45. Valentino LA. Blood-induced joint disease: the pathophysiology of hemophilic arthropathy. J Thromb Haemost 2010; 8: 1895-902.
46. Hakobyan N et al. Pathobiology of hemophilic synovitis I: overexpression of mdm2 oncogene. Blood 2004; 104: 2060-4.
47. Wen FQ et al. c-myc proto-oncogene expression in hemophilic synovitis: in vitro studies of the effects of iron and ceramide. Blood 2002; 100: 912-6.
48. Hoots WK. et al. Pathogenesis of haemophilic synovitis: clinical aspects. Haemophilia 2007; 13: 4-9.
49. Lafeber FP, Miossec P, Valentino LA. Physiopathology of haemophilic arthropathy. Haemophilia 2008; 14: 3-9.
50. Valentino LA, Hakobyan N, Enockson C. Blood-induced joint disease: the confluence of dysregulated oncogenes, inflammatory signals, and angiogenic cues. Semin Hematol 2008; 2: S50-7.
51. Manco-Johnson MJ et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007; 357: 535-44.
52. Doria AS et al. Reliability of progressive and additive MRI scoring systems for evaluation of haemophilic arthropathy in children: expert MRI Working Group of the International Prophylaxis Study Group. Haemophilia 2005; 11: 245-53.
53. Doria AS et al. Reliability and construct validity of the compatible MRI scoring system for evaluation of elbows in haemophilic children. Haemophilia 2008; 14: 303-14.
54. Feldman BM et al. Musculoskeletal measurement tools from the International Prophylaxis Study Group (IPSG). Haemophilia 2008; 14: 162-9.
55. Kilcoyne RF, Lundin B, Pettersson H. Evolution of the imaging tests in hemophilia with emphasis on radiography and magnetic resonance imaging. Acta Radiol 2006; 47: 287-96.
56. Lundin B et al. Compatible scales for progressive and additive MRI assessments of haemophilic arthropathy. Haemophilia 2005; 11: 109-15.
57. Lundin B et al. Gadolinium contrast agent is of limited value for magnetic resonance imaging assessment of synovial hypertrophy in hemophiliacs. Acta Radiol 2007; 48: 520-30.
58. Doria AS. State-of-the-art imaging techniques for the evaluation of haemophilic arthropathy: present and future. Haemophilia 2010; 16: 107-14.
59. Jansen NW et al. The combination of the biomarkers urinary C-terminal telopeptide of type II collagen, serum cartilage oligomeric matrix protein, and serum chondroitin sulfate 846 reflects cartilage damage in hemophilic arthropathy. Arthritis Rheum 2009; 60: 290-8.
60. Einhorn TA, Majeska RJ, Rush EB et al. The expression of cytokine activity by fracture callus. J Bone Miner Res 1995; 10: 1272-81.
61. Friedlaender GE, Perry CR, Cole JD et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg 2001; 83A: S151-8.
62. Schmidmaier G, Wildemann B, Ostapowicz D et al. Long-term effects of local growth factor (IGF-I and TGF-beta 1) treatment on fracture healing. A safety study for using growth factors. J Orthop Res 2004; 22: 514-9.
63. Roldan JC, Jepsen S, Miller J et al. Bone formation in the presence of platelet-rich plasma vs. bone morphogenetic protein-7. Bone 2004; 34: 80-90.
64. Garrison KR, Shemilt I, Donell S et al. Bone morphogenetic protein (BMP) for fracture healing in adults. Cochrane Database Syst Rev 2010; 16: CD006950.
65. Argintar E, Edwards S, Delahay J. Bone morphogenetic proteins in orthopaedic trauma surgery. Injury 2011; 42: 730-4.
66. Jansen NWD, Roosendaal G, Lafeber FPJG. Understanding haemophilia arthropathy: an exploration of current open issues. Br J Haematol 2008; 143: 632-40.
67. Valentino LA, Hakobyan N, Rodriguez N, Hoots WK. Pathogenesis of haemophilic synovitis: experimental studies on blood-induced joint damage. Haemophilia 2007; 13: 10-3.
68. World Federation of Hemophilia. Guidelines for the Management of Hemophilia. Montreal: World Federation of Hemophilia publication, 2005: 7, 8, 23, 24.
69. Southmayd W, Hoffman M. Sports Health: The Complete Book of Athletic Injuries. New York: Quick Fox, 1981.
70. American Academy of Orthopedic Surgeons. Sprains, strains and other soft-tissue injuries. Patient information library. Available at Accessed December 2011.
71. Bahn SL, Mursch PI. The effects of cold on hemostasis. Oral Surg 1980; 49: 294-300.
72. Niemczura RT, DePalma RG. Optimum compress temperature for wound hemostasis. J Surg Res 1979; 26: 570-3.
73. Valeri CR, MacGregor H, Cassidy G, Tinney R, Pompei F. Effects of temperature on bleeding and clotting time in normal male and female volunteers. Crit Care Med 1995; 4: 698-704.
74. Romlin B, Petruson K, Nilsson K. Moderate superficial hypothermia prolongs bleeding time in humans. Acta Anaesthesiol Scand 2007; 51: 198-201.
75. Rundgren M, Engstrom M. A thromboelastometric evaluation of the effects of hypothermia on the coagulation system. Anesthes Analg 2008; 107: 1465-8.
76. Palmer JE, Knight KL. Ankle and thigh skin surface temperature changes with repeated ice pack application. J Athl Train 1996; 31: 319-23.
77. Kennet J, Hardaker N, Hobbs S, Selfe J. Cooling efficiency of 4 common cryotherapeutic agents. J Athl Train 2007; 42: 343-8.
78. Warren TA, McCarty EC, Richardson AL, Michener T, Spindler KP. Intra-articular knee temperature changes: ice versus cryotherapy device. Am J Sports Med 2004; 32: 441-5.
79. Oosterveld FG, Rasker JJ, Jacobs JW, Overmars HJ. The effect of local heat and cold therapy on the intraarticular and skin surface temperature of the knee. Arthritis Rheum 1992; 35: 146-51.
80. Sanchez-Inchausti G, Vaquero-Martin J, Vidal-Fernandez C. Effect of arthroscopy and continuous cryotherapy on the intra-articular temperature of the knee. Arthroscopy 2005; 21: 552-6.
81. Bocobo C, Fast A, Kingery W, Kaplan M. The effect of ice on intra-articular temperature in the knee of the dog. Am J Phys Med Rehabil 1991; 70: 181-5 (Fig. 2b).
82. Collins NC. Is ice right? Does cryotherapy improve outcome for acute soft tissue injury? Emerg Med J 2008; 25: 65-8.
83. Bleakley C, McDonough S, MacAuley D. The use of ice in the treatment of acute soft-tissue injury: a systematic review of randomized controlled trials. Am J Sport Med 2004; 32: 251-61.
84. Hemophilia in Pictures. Educator's Guide. Montreal: World Federation of Hemophilia Publication, 2008: p. 23.
85. Rivard G, Blanchette V, Hilliard P, Mulder K, Zourikian N. All About Hemophilia: A Guide for Families. Montreal: Canadian Hemophilia Society publication, 2010. Chapter 4: p. 2 and 4.
86. Chandy M. Treatment options in the management of hemophilia in developing countries. Montreal: World Federation of Hemophilia publication, December 2005: 3.